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Aim of the Study  
Endocrine disrupting chemicals (EDC) are exogenous agents that are capable of altering the 
endocrine system functions, including the regulation of developmental processes. The aim of 
this study was to investigate the association between endocrine disrupting chemicals (EDC) 
exposure and other parental factors in the aetiology of hypospadias and cryptorchidism. 
Methods 
A case-control study was conducted. Cases (210) were infants between 6 months and 14 years 
of age diagnosed with hypospadias or cryptorchidism attended in our hospital over a period of 
18 months, and controls (210), infants within the same range of age and without any urological 
disorders who attended the outpatient clinic of the same hospital during the same. Their 
selection was independent of exposures. Data on parental occupational exposure to EDC and 
other sociodemographic variables were collected by face-to-face interviews and systematically 
for both cases and controls. Crude and adjusted odds ratios (OR) were estimated to control for 
confounding with their 95% CI by means of logistic regressions. Specifically, three final models 
of dichotomous outcome were constructed: one for cryptorchidism, one for hypospadias, and 
the third considering both malformations together. Hosmer-Lemeshow test was used to assess 
the goodness-of-fit of the models. Their discriminatory accuracy (DA) was ascertained by 
estimating their areas under the receiver-operating-characteristics (ROC) curves (AUC) along 
with their 95%CI.  
Results 
Associations were found between advanced maternal age (OR adjusted=1,82; 95%CI: 1,14-
2,92), mother´s consumption of antiabortives (OR=5.40; 1.40-38.5) and other drugs (OR=2.02; 















8.96 and 3.90; 2.41-6.48), respectively, fathers smoking (OR=2.0; 1.33-2.99) and with 
urological disorders (OR=2.31; 1.15-4.90). Maternal and paternal high educational level could 
be protective of cryptorchidism (OR=0.47; 0.28-0.76) and OR=0.63; 0.42-0.93, respectively). 
The discriminatory accuracy of the models for the whole sample (AUC=0.75; 0.70-0.79), for 
cryptorchidism (0.76; 0.71-0.82), and for hipospadias (0.75; 0.69-0.81) was moderately high.  
Conclusions  
Advanced age, some parental occupational exposure to EDC, some drugs consumption, 
smoking and the father´s history of urological disorders may increase risk and predict the 
developments of these malformations. Studies with higher samples sizes are needed to assess 
associations between individual EDC occupational exposures and drugs and these 




 The ability of some synthetic chemicals to interfere with the human hormonal system 
has been known since the 1940s when diethylstilbestrol (DES) started to be used to prevent 
spontaneous abortions [1]. However, the term “endocrine disruptor” was not defined until 
1991 during the Wingspread Conference in Wisconsin [2] where a group of experts met to 
assess the causes of health problems observed in people and animals from developed 
countries including disorders of the reproductive system. An endocrine disrupting chemical 
(EDC) was then defined as an exogenous substance capable of altering the hormonal balance 
and causing adverse effects on an organism or its progeny.  
 Most of these exogenous chemicals have an estrogenic and anti-androgenic effect and 















genital differentiation in animals [3] and humans [4]. Most of them are lipophilic and may 
remain in the body fat for many years; they can reach the fetus across the placenta during 
pregnancy and the newborn during breastfeeding [5], and eventually affect the newborn 
health. Mankind produces the vast majority of these substances, which are present on the 
environment as industrial pollutants, pesticides, plastics and cosmetic products among others. 
 In 1993, R. Sharpe and N. Skakkebaek hypothesized that “the increasing incidence of 
reproductive abnormalities in the human male may be related to increased estrogen exposure 
in utero” [6]. Since then, several studies have attempted to demonstrate the role that 
environmental EDC may have in hypospadias and cryptorchidism etiology by trying to find 
associations between them [7–9]. The aim of the present study was to investigate the 
association and the discriminatory accuracy of alleged risk factors associated with both 
malformations development, including parental occupational and non-occupational exposures 
to EDC.       
 
Materials and methods 
Study design 
 We conducted a case-control study at the Miguel Servet University Hospital of 
Zaragoza, reference´s center in Pediatric Urology for population of the Spanish Autonomous 
Communities of Aragon, La Rioja and the province of Soria, where the proportion of population 
employed in industrial and agricultural activities is considerable. All cases and controls were 
Caucasian. 
 As cases, we included children aged between 6 months and 14 years diagnosed with 
cryptorchidism and/or hypospadias in the outpatient of Pediatric Urology for a period of 18 















presented one or both non-descended testicles into the scrotum and who underwent an 
orchidopexy surgery. All cases were at least 6 months old to exclude the cases with a delayed 
descent of the testis. Patients with acquired undescended testis were excluded. Cases of 
hypospadias were defined as those with displacement of the urethral opening anywhere along 
the shaft in the ventral position of the penis, including proximal and distal forms. All patients 
with endocrine or genetic cause of hypospadias and/or cryptorchidism (2 cases of DSD and 1 
case of congenital adrenal hyperplasia) were excluded as cases.  
  
 In the control group, we included children with the same range of age who attended to 
Pediatric Surgery and General Pediatrics outpatient clinics during the same period at the same 
center, after a clinical examination confirming a normal configuration of external genitalia and 
no history of inguinal/genital surgery or endocrine disease. Their selection was independent of 
exposures. No hospitalized patients were included. 
   
Data collection 
 After approval from our Institutional Review Board and upon informed consent of the 
family, data were collected through an epidemiological questionnaire that was performed by 
face-to-face interview with both parents in the consulting room. All of those invited agreed to 
participate. Only 9.6% of the cases did not complete the whole questionnaire, so we had to 
draw the missing data from the electronical medical records. The epidemiological 
questionnaire included mainly three groups of variables. 
 Patient´s data: gestational age, birth weight, presence of others malformations at birth 
and family history of hypospadias and/or cryptorchidism. Mother´s data: age at delivery, 















school with job training; high: completed high school and university studies), profession prior 
and during conception period (those entailing direct exposure to substances already described 
in the previous literature as EDC), occupational exposure to EDC and obstetric history (use of 
contraceptives, tobacco and alcohol consumption, use of drugs during pregnancy, if it was a 
natural pregnancy or in vitro fertilization (IVF), previous abortions, parity and gynecological 
diseases). Father´s data: age at patient´s birth, educational level, tobacco and alcohol 
consumption, profession prior and during conception period, occupational exposure to EDC 
and urological history.  
 Regarding parental profession, we defined four professional categories “of risk” 
because of their specific exposure to EDC: agriculture (e.g. pesticides, chlorinated insecticides, 
dicarboximide fungicides), industry (e.g. bisphenol A, polychlorinated biphenyls, dioxins) 
cleaners and hairdressers (e.g. phthalates and parabens).  
Data analysis  
 For descriptive statistics, measures of central tendency (mean ± standard deviation) 
were estimated for all quantitative variables and on qualitative variables, percentages with 
their 95% confidence intervals (CI) were calculated. To compare data obtained in each group, 
we used parametric and non-parametric statistical tests for continuous variables (T test and U-
Mann-Whitney test, respectively) and Chi-square and Fisher's exact tests when necessary for 
categorical data. A p-value of < 0.05 was defined as statistically significant. 
 Then for the analysis of alleged risk factors, we estimated both crude and adjusted 
odds ratios (OR) to control for confounding with their 95% CI by means of logistic regressions. 
Specifically, three final models of dichotomous outcome were constructed: one for 
cryptorchidism, one for hypospadias, and the third considering both malformations together. 
We did so mainly for two reasons: 1) to take into consideration the hypothesis considered in 















ascertain if the results concerning the associations changed when analyzing them separately, 
thus trying to add more insights in an attempt to contribute to clarify this issue. Hosmer-
Lemeshow test was used to assess the goodness-of-fit of the models.  
 Average measures of association between putative risk factors and outcomes are 
unsuitable for ascertaining their performance. Even strong associations (OR or RR > 10) have a 
low capacity of both risks factors and biomarkers to discriminate between cases and noncases 
in the population. Exposures with very high disease risks have a low population prevalence and 
account for a small fraction of cases. Therefore, average measures of association ought to be 
interpreted in tandem with measures of discriminatory accuracy [7,8]. For these reasons, their 
discriminatory accuracy (DA) was ascertained by estimating their areas under the receiver-
operating-characteristics (ROC) curves (AUC or C statistic) along with their 95%CI. The 
statistical analyses were performed using SPSS v.20 software. 
 
Results 
A total of 420 patients were studied, 210 cases and 210 controls with a mean age of 
3.37±2.64 years (range 0.5-12). Cases included 107 patients with hypospadias and 103 with 
cryptorchidism; eight cases presented both malformations (3.8%). Table 1 shows the 
prevalence of exposure to the alleged risk factors considered in the study for cases, controls, 
and the general population. The only difference found in the fraction of exposed between 
controls and the general population was mother´s age. We did not find general population 
estimates of mother´s and father´s occupational EDC exposure and antiabortives. 
 
Regarding perinatal factors, no statistically significant differences were found between 
birth weight (BW) medians of cases and controls (3,067 ± 0,653kg versus 3,110 ± 0,596kg 















hypospadias group compared with the controls (2,929 ± 0,682kg versus 3,360 ± 0,590kg 
respectively, p = 0.01). Later, when this variable was dichotomized in low birth weight (LBW) 
and no-LBW (defined as < 2500 grams), a significant increase of the crude OR was observed in 
hypospadias group (OR = 2.24; 95% CI: 1.20-4.17). No differences between cases and controls 
were found (38 ± 2, 42 and 37, 93 ± 1, 91 weeks respectively, p = 0.75) regarding medians of 
gestational age (GA). When this variable was considered categorical, the percentage of 
preterm births (defined as a GA < 37 weeks) was significantly higher in cases than in controls 
both for the whole sample (19 versus 10%, p = 0.02) and for the hypospadias group (19.6% 
versus 10.5%, p = 0.02). An increased OR for prematurity was also observed in hypospadias 
group (OR = 2.21; 95% CI: 1.16-4.21).  
 
The most frequent associated malformation in cases was inguinal hernia with an 
incidence of 1.2%. No statistically significantly differences were found for the presence of 
other malformations at birth between cases and controls (9.5% versus 8% respectively; p = 
0.50). The difference between the frequency of family history of hypospadias and/or 
cryptorchidism between cases (23, 10.9%) and controls (6, 2.9%) was also statistically 
significant (p = 0.001). In cryptorchidism group, 11.6% of subjects had family history of 
cryptorchidism, 4 of them in siblings, 3 in parents, 4 in paternal uncles and 1 in a paternal 
cousin; and in hypospadias group six patients had family history of hypospadias, 3 of them in 
siblings and 3 in their parents.  
 
Tables 2, 3 and 4, show the adjusted ORs of the alleged parental risk factors for the 
pooled sample, and for cryptorchidism and hypospadias separately, estimated with the final 
logistic regression models chosen on the basis of their goodness of fit and discriminant 
accuracy. According to the adjusted ORs and their 95%CI, when considered together 















paternal EDC exposure, smoking fathers, antiabortives and other drugs consumption during 
pregnancy. No conclusion can be drawn for either advanced paternal age or father´s urological 
history since their 95%CI include 1.0. They were kept in the final models because their 
inclusion increased both their goodness-of-fit and discriminant accuracy.  
 
Alleged risk factors associated with cryptorchidism were advanced maternal age, 
paternal and maternal EDC exposure, paternal smoking, and antiabortives. Those associated 
with hypospadias were advanced maternal age, paternal EDC exposure, father smoking, and 
other drugs consumption.  
 
No conclusion can be drawn from the association between father´s urological history 
with cryptorchidism and hypospadias when considered separately. Since their 95%CI include 
1.0 their association with these malformations could be both direct or inverse despite more 
values of the 95%CI are consistent with a direct association. The same applies to maternal 
education level but only with regard to its exclusive association with cryptorchidism, and to in 
vitro fertilization with hypospadias. Paternal education level appears to have an association 
only with cryptorchidism, which is the only clear inverse association of all found. Therefore, 
advanced maternal age, paternal EDC exposure, and smoking are the only alleged risk factors 
associated with both cryptorchidism and hypospadias. When stratifying the analyses by 
fathers´ and mothers´ exposure to EDC for cryptorchidism and hypospadias separately, no 
differences were found compared with the pooled analyses.  
 
No results could be obtained concerning the DA of each of the individual alleged risk 
factors given their small sample sizes. Nevertheless, when these factors are considered 
together, their DA, as indicated by the AUC of each model, is moderately high because the 















cryptorchidism and for hypospadias) is 0.70. The final models fit the data quite well (Tables 2, 
3 and 4).  
 
Discussion  
 Several factors have been considered as possible risk factors of cryptorchidism and 
hypospadias in the scientific literature. Regarding perinatal factors, LBW and prematurity have 
been classically associated with cryptorchidism and hypospadias [9–12]. However, we only 
could confirm this observation in hypospadias group in the bivariate analyses, not in the final 
multivariate models. These two variables are strongly dependent on each other and associated 
with suboptimal first-trimester intrauterine growth. Their association with hypospadias may be 
related to early placental dysfunction causing insufficient amounts of androgen production 
affecting male genital development [16]. Accordingly, hypospadias has been associated with 
both low weight of the placenta [17] and preeclampsia later during pregnancy [18].  
 Regarding familiar history of cryptorchidism, our results would support the previous 
familiar predisposition described in cryptorchidism development and not only in first-degree 
relatives [16,17]. In hypospadias group, the familiar prevalence observed (5.6%) was similar or 
slightly lower than the 7% incidence described in a nationwide cohort study conducted by 
Schnack et al. [21]. Moreover, a significant increase in risk was observed in relation to the 
presence of family history of cryptorchidism and/or hypospadias in all the groups, but only in 
the bivariate analysis. These results would support the genetic predisposition previously 
described in the literature for both malformations and clearly highlight the importance of 
genetic factors in their pathogenesis. 
 Concerning maternal factors, mother´s age appears to be associated with both 
cryptorchidism and hypospadias, what is consistent with other studies, and has been 















persistent chemicals [15,19–21]. We also found an association between antiabortives and 
other drugs consumption during pregnancy in all the groups. As antiabortives, we include 
drugs used both to prevent an abortion threat (medroxyprogesterone acetate) and to suppress 
preterm labor (ritodrine and nifedipine). Our results are consistent with those of other studies 
suggesting a potential etiological effect of some drugs on cryptorchidism and hypospadias 
development [22,23]. As for other drugs consumption, the most frequently drugs used were 
hormones (46.5%), followed by analgesics and antipyretics (19.5%), which have been found to 
increase the risk of cryptorchidism and hypospadias in other studies [24,25]. Moreover, 
mothers receiving hormone replacement therapy during pregnancy (mainly insulin and 
levothyroxine) had Diabetes Mellitus or hypothyroidism, what has also been related to an 
increase in cryptorchidism and hypospadias [20,26,27]. We could not assess the associations 
between each drug and hypospadias and cryptorchidism given the small sample sizes.  
 Regarding paternal factors, we also found a significant increased risk in smoking 
fathers. Paternal smoking had been previously associated with the occurrence of multiple birth 
defects [30] and specifically with hypospadias by Pierik et.al [14]; our results suggest that it 
could be associated with hypospadias and also with cryptorchidism development. Maternal 
smoking exposure have been reported as a risk factor for both malformations, and paternal 
smoking could have an effect through passive exposure of the mother. On the other hand, and 
similarly to EDC exposure, tobacco could affect offspring by epigenetic effects on germ cells 
(e.g. DNA repair, chromatin structure, apoptosis), whereas exposure of the oocyte or embryo 
to contaminated seminal fluid could also play a role [31].  
 As for environmental factors, both maternal and paternal EDC occupational exposures 
were found to be associated with an increased risk for both malformation in the pooled 
sample and in the cryptorchidism group. For mothers, the percentage of exposed was 















agriculture categories. These results are consistent with the endocrine disruption hypothesis 
previously described by Sharpe and Skakkeabeak [6] and with data previously described in 
literature. In 2003, Vrijheid et al. found an increased risk of hypospadias in children whose 
mother were hairdressers [32]. Similarly, in a case-control study including 408 patients with 
hypospadias, the percentage of parents exposed to toxics during work was significantly higher 
in cases than in controls and within the cases, the most frequent maternal profession was 
hairdresser [8]. Moreover, in a Danish cohort study conducted, hairdressing and agriculture 
were the parental professions most frequently described among the parents of patients with 
cryptorchidism and hypospadias [33], and others found an increased risk of hypospadias and 
cryptorchidism in children of farming parents [14]. Regarding industry, some studies reported 
a higher incidence of hypospadias and cryptorchidism in children of parents who lived close to 
industrial zones [31-33].  
 Contrarily, an inverse association was found between fathers and mothers educational 
level and cryptorchidism. This could be explain because of the direct relation that educational 
level have with the professional category, as parents with a high-educational level will not 
probably work as hairdressers, farmers or industry workers and will have less probabilities of 
being exposed to EDC in their working place.  
  This study has some potential limitations. The low sample sizes do not allow to look 
for individual associations between both malformations and individual drug´s consumption, 
EDC exposures to specific toxics and professions. The fact that controls were drawn from the 
hospitals could introduce a selection bias, including Bergson´s bias. However, excluding 
mother´s age, the percentage of controls exposed to the alleged risk factors was similar to that 
of the general population thus impeding the introduction of these biases. The prevalence of 
control mothers > 35 years being lower than in the general population could overestimate the 















magnitude of some associations could also be overestimated due to differential recall between 
parents of cases and controls concerning their exposures. Unbiased population estimates of 
the prevalence of mother´s and father´s EDC occupational exposure and the consumption of 
antiabortives are lacking, precluding drawing conclusions about selection bias regarding these 
risk factors. The unambiguous diagnoses of both malformations, and the systematic way in 




 Hypospadias and cryptorchidism are both multifactorial pathologies in which genetic 
and environmental factors are implicated. According with our results, advanced maternal age, 
maternal and paternal EDC occupational exposure, antiabortives and other drugs consumption 
could be risk factors for both malformations development, LBW and prematurity could be risk 
factors for hypospadias and the parental high-educational level could have a protecting effect 
for cryptorchidism. Further studies with a wider variety of population controls and higher 
statistical power are needed particularly, to focus on the associations between individual EDC 
occupational exposure and drugs and these two malformations, and to confirm our findings.  
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Summary table  Adjusted ORs for alleged parental risk factors in the whole sample  
Parental variables  OR IC 95% OR 
Inferior limit Upper limit 
Advanced maternal age 1,82 1,14 2,92 
Maternal EDC exposure 3,48 1,57 7,67 
Antiabortives 5,57 1,08 28,75 
Other drugs consumption 2,22 1,36 3,62 
Advanced paternal age 1,36 0,81 2,26 
Paternal EDC exposure 4,20 2,48 7,11 
Smoking fathers 2,07 1,32 3,26 
Father´s urological history 2,10 0,95 4,62 
Constant 0,26  

















Table 1 Prevalence of exposure to alleged risk factors in cases and controls 
 
 
















Mother´s age  
< 25 years 6.19 6.19  15.4 
25-35 years 50.96 63,34  35.8 
> 35 years 42.85 30.47 0.033 49.7 
Mother´s educational level  
basic  34.76 28.10  28 
medium 35.23 26.19  22 
high 31.01 45.71 0.004 40 
Mother´s occupational EDC exposure  
No 82.9 95.2   
Yes 17.1 4.8 < 0.001 Unknown 
Mother´s professional category  
Agriculture 1.9 1.0   
Cleaners 2.9 3.8   
Hairdressers 6.2 0 0.016 Unknown 
Industry 4.8 4.3   
Mother´s tobacco consumption  
No 83.3 85.2   
< 10 cigarettes/day 15.2 12.4 0.556  
> 10 cigarettes/day 1.4 2.4   
Mother´s alcohol consumption  
No 98.6 99   
1-7 glasses/week 1.4 1.0 0.652  
> 8 glasses/week 0 0   
Contraceptives   
No 64.8 63.3   
Yes 35.2 36.7 0.419  
Antiabortives     
No 94.8 99   
Yes 5.2 1 0.024 Unknown 
Other drugs consumption during pregnancy  
No  65.7 79.5   
Yes 34.3 20.5 0.002 15-20 
In vitro fertilization  
No 7.6 3.8   
Yes 92.4 96.2 0.141  
Previous abortions  
No 98.1 98.6   
Yes 1.9 1.4 0.703  
Parity  
Primiparous 49 43.8   
Multiparous 51 56.2 0.328  
Gynecological diseases  
No 88.1 87.1   
Yes 11.9 12.9 0.882  













< 40 years 70 76.7  74.11 
> 40 years 30 23.3 0.151 25.9 
Father´s educational level  
basic  47.6 34.8   
medium 35.7 26.2   
high 16.7 39 < 0.001  
Father´s occupational EDC exposure  
No 63.3 87.1   
Yes 36.7 12.9 < 0.001 Unknown 
Father´s professional category  
Agriculture 9 2.9 0.002 2.7 
Cleaners 0.5 0.5   
Hairdressers 0.5 0   
Industry 15.7 7.1 0.002 7.8 
Father´s tobacco consumption  
No 56.2 71.9   
< 10 cigarettes/day 18.6 10.5   
> 10 cigarettes/day 25.2 17.6 0.003 25 
Father´s alcohol consumption  
No 43.3 51.9   
1-7 glasses/week 53.8 43.3   
> 8 glasses/week 2.9 4.8 0.082 22,6 
Urological diseases  
No 87.6 94.3   















Table 2 Adjusted ORs for alleged parental risk factors in cryptorchidism group  
Parental variables OR 95% CI 
Inferior limit Upper limit 
Advanced maternal age 1,95 1,04 3,64 
Maternal EDC exposure 5,46 2,32 12,83 
Maternal educational level 0,66 0,35 1,23 
Antiabortives 7,54 1,29 44,21 
Advanced paternal age 1,26 0,66 2,40 
Paternal EDC exposure 2,79 1,47 5,30 
Paternal educational level 0,50 0,27 0,93 
Smoking fathers 1,71 0,99 2,98 
Father´s urological history 1,79 0,66 4,89 
Constant 1,01  
Goodness-of-fit: Hosmer-Lemeshow chi-square =  4.88; p = 0.77. 
 
 
Table 3 Adjusted ORs for alleged parental risk factors in hipospadias group  
Parental variables OR IC 95% OR 
Inferior limit Upper limit 
Advanced maternal age 2,36 1,37 4,06 
Other drugs consumption 2,60 1,47 4,62 
In vitro fertilization 0,37 0,13 1,04 
Paternal EDC exposure 5,07 2,76 9,31 
Smoking fathers 2,12 1,22 3,70 
Father´s urological history 2,39 0,98 5,84 
Constant 0,90  


















Figure 1 ROC curves showing the discriminant accuracy of the three predictive models  
             Whole sample     Cryptrochidism group   Hypospadias group  
 
AUC =0.75; 95%CI:0.70-0.79.  AUC = 0.76; 95%CI: 0.71-0.82.  AUC = 0.75; 95%CI: 0.69-0.81. 
 
 
 
